Maternal Health Market Size was valued at USD 23.9 Billion in 2023. The Maternal Health market industry is projected to grow from USD 27.46 Billion in 2024 to USD 72.6 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 14.60% during the forecast period (2024 - 2032). More parents are willing to meet with super-specialists and more people are seeking out maternal health care, are the key market drivers enhancing the market growth.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The increase in demand for these services is the primary factor fueling the Maternal Health market's expansion. The Maternal Health sector is growing as a result of parents' inclination to consult with super-specialists. Maternal health care is among the top priority for community health programmes. According to the World Health Organisation, maternal health services include "promoting, preventing, therapeutic, or rehabilitation facility or care for mother and child." Health problems are also becoming more widely known. However, the majority of developing countries are unable to achieve the anticipated reductions in child and maternal mortality because of insufficient access to healthcare services and a lack of awareness. Countries like India, Bangladesh, Thailand, and Sri Lanka need to increase the quality of maternal and child care by enhancing financial incentives for health care and raising funds for the proper utilisation of current resources. For instance, the Indian government offers a variety of services in India, including as the Janani Suraksha Yojana, Janani Express, 1098 service, facility-based newborn care service, and home-based newborn care service.
Additionally, maternal health services monitor children's development, food, and mental health as well as provide a healthy environment for both mothers and children in order to reduce infant and maternal mortality as well as morbidity. It is also possible to prevent or manage direct causes of maternal mortality, such as haemorrhage, obstructed labour, and decreased foetal and neonatal fatalities associated with obstetric difficulties, by utilising proper utilisation and adequate care. The demand for Maternal Health services will rise as a result, thus driving market expansion.
Pregnant women utilise a range of healthcare options all around the world. The out-of-pocket costs for maternity care vary depending on a variety of factors, including the care model used, insurance coverage, and the decision made by women to receive health treatments outside the scope of typical maternity care. India's Out-Of-Pocket Expenditure (OOPE) is higher than many other emerging countries in Asia and Africa with slower economic growth and smaller economies, according to the WHO Health Expenditure Database. The WHO estimates that roughly 86% of India's healthcare costs are covered by OOPE expenses, which supports the market's expansion.
The healthcare sector's explosive growth is one of the primary factors supporting a bullish outlook for the market. Maternal health practises are widely adopted by parents in order to consult with super-specialist doctors and safeguard the health of both mother and child. The market is being encouraged to grow by the widespread use of maternal health services by expectant mothers as a result of the difficulty of giving birth without the assistance of medical experts who have the requisite skills, as well as the absence of or limited access to prenatal care. A further factor driving market expansion is the availability of several nutritional and micronutrient supplementation alternatives, including those for iron, zinc, calcium, and early prenatal meals. In addition to providing the mother and child with the essential levels of vital nutrients, these supplements help protect them from diseases and infections. In keeping with this, the ease of use of digital claim processing and healthcare policy management systems is positively affecting market growth. The market is anticipated to grow as a result of a number of other factors, including the growing number of women who have the immunodeficiency virus and other chronic illnesses, the implementation of several government initiatives to improve public health, and a number of other factors. Thus, driving the Maternal Health market revenue.
The Maternal Health market segmentation, based on Type of Pregnancy, includes Intrauterine, Ectopic, Tubal, and Others. Intrauterine segment dominated the market in 2022. This is explained by the rising preference for and understanding of maternal health.
The Maternal Health market segmentation, based on Complication, includes Miscarriage, Premature Labor & Birth, Preeclampsia, Gestational Diabetes, Placenta Previa, and Others. Miscarriage segment dominated the market in 2022. This is a result of the increased need for maternal health care caused by the rise in miscarriages globally.
The Maternal Health market segmentation, based on Care, includes Prenatal Care and Postnatal Care. Prenatal care segment dominated the Maternal Health market in 2022. This can be explained by the attention given in this type of care. For instance, care includes both the prevention of health problems and the early identification and treatment of those problems.
Figure 1: Maternal Health Market, by Care, 2023 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
By region, the study provides the market insights into North America, Europe, Asia-Pacific and Rest of the World. The Asia Pacific Maternal Health market dominated this market in 2022 (45.80%). This is due to a number of factors, including a lack of facilities offering super-specialty care, parents' increased willingness to consult super-specialists, the expansion of the region's developed healthcare infrastructure, and ongoing research efforts for the development of cutting-edge technologies and services. Moreover, China’s Maternal Health market held the largest market share and the Indian Maternal Health market was the fastest growing market in the Asia-Pacific region.
Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.
Figure 2: MATERNAL HEALTH MARKET SHARE BY REGION 2023 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
The North America Maternal Health Market is expected to register significant growth from 2023 to 2032. North America presents lucrative opportunities for players in the mother and child healthcare market due to its large population, growing awareness of maternity services and fertility treatments, rising in vitro fertilisation (IVF) popularity in the United States, rising infertility rates, technological advancements, and delayed pregnancy trends. A rise in the trend of women delaying childbirth is also anticipated to fuel market expansion.Further, the U.S. Maternal Health market held the largest market share, and the Canada Maternal Health market was the fastest growing market in the North America region.
Europe Maternal Health market accounted for the healthy market share in 2022. In order to assist with health system reform, national professional staff are stationed in the WHO country offices, and WHO/Europe has continuing partnership agreements on this particular issue with a number of countries. International market behemoths have also made major investments in the area.Further, the German Maternal Health market held the largest market share, and the U.K Maternal Health market was the fastest growing market in the European region.
Leading market players are investing heavily in research and development in order to expand their product lines, which will help the Maternal Health market, grow even more. Market participants are also undertaking a variety of strategic activities to expand their footprint, with important market developments including new product launches, contractual agreements, mergers and acquisitions, higher investments, and collaboration with other organizations. To expand and survive in a more competitive and rising market climate, Maternal Health industry must offer cost-effective items.
Manufacturing locally to minimize operational costs is one of the key business tactics used by manufacturers in the Maternal Health industry to benefit clients and increase the market sector. In recent years, the Maternal Health industry has offered some of the most significant advantages to medicine. Major players in the Maternal Health market, including Agile Therapeutics, Sanofi, Okamoto Industries, Fuji Latex Co, Reckitt Benckiser Group, and Johnson and Johnson, are attempting to increase market demand by investing in research and development Type of Pregnancys.
A publisher of medical books is Cleveland Clinic. A variety of subjects are covered by the company's publications, including rheumatoid arthritis, heart attacks, women's health, ageing, cancer, diabetes, infertility, and health literacy. These writings aim to refute common misconceptions regarding medications, healthcare, and medical procedures. The National Institutes of Health awarded Cleveland Clinic a USD 14.2 million grant for atrial fibrillation research in July 2022. The most prevalent cardiac rhythm problem, atrial fibrillation, will be treated better and in new ways for patients thanks to four synergistic initiatives supported over a five-year period.
Sanofi, a healthcare organisation, is involved in the development, production, marketing, and discovery of numerous drugs and vaccines. It also offers human immunisations for defence against a number of bacterial and viral diseases, as well as multiple sclerosis, cancer, and other treatments. The company also sells supplements, vitamins, minerals, and goods for women's health, digestion, allergy, cough, cold, flu, and sinus infections, as well as products for pain. The majority of Sanofi's research and development activities are directed towards developing combination therapies to boost treatment efficacy and towards developing innovative biologic formulations to manufacture precision medicines. It operates throughout the Middle East, Africa, Asia-Pacific, and the Americas. The corporate office of Sanofi is located in Paris, Ile-de-France, France.
Agile Therapeutics
Sanofi
Okamoto Industries
Fuji Latex Co
June 2022:People with obesity who underwent weight-loss surgery had a 32% lower risk of developing cancer and a 48% lower risk of dying from it, per Cleveland Clinic research. The research was published in JAMA.
Intrauterine
Ectopic
Tubal
Others
Miscarriage
Premature Labor & Birth
Preeclampsia
Gestational Diabetes
Placenta Previa
Others
Prenatal Care
Postnatal Care
North America
U.S.
Canada
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Australia
Rest of Asia-Pacific
Rest of the World
Middle East
Africa
Latin America
| Report Attribute/Metric | Details |
| Market Size 2022 | USD 20.8 Billion |
| Market Size 2023 | USD 23.9 Billion |
| Market Size 2032 | USD 72.6 Billion |
| Compound Annual Growth Rate (CAGR) | 14.60% (2024-2032) |
| Base Year | 2023 |
| Market Forecast Period | 2024-2032 |
| Historical Data | 2018- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Type of Pregnancy, Complication, Care, and Region |
| Geographies Covered | North America, Europe, Asia Pacific, and the Rest of the World |
| Countries Covered | The U.S., Canada, German, France, U.K, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil |
| Key Companies Profiled | Agile Therapeutics, Sanofi, Okamoto Industries, Fuji Latex Co, Reckitt Benckiser Group, and Johnson and Johnson |
| Key Market Opportunities | Growing customer awareness regarding benefits of maternal health |
| Key Market Dynamics | Increase in adoption of mother and child healthcare services and willingness among parents to seek opinion from super-specialists |
Frequently Asked Questions (FAQ) :
The Maternal Health market size was valued at USD 20.8 Billion in 2022.
The market is projected to grow at a CAGR of 14.60% during the forecast period, 2024-2032.
Asia Pacific had the largest share in the market
The key players in the market are Agile Therapeutics, Sanofi, Okamoto Industries, Fuji Latex Co, Reckitt Benckiser Group, and Johnson and Johnson
The Intrauterine Type of Pregnancy dominated the market in 2022.
The Miscarriage Complication had the largest share in the market.
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
Research Analyst Level I He is an extremely curious individual currently working in healthcare and medical devices domain. kinjoll is comfortably versed in data centric research backed by healthcare educational background. he leverages extensive data mining and analytics tools such as primary and secondary research, statistical analysis, machine learning, data modelling. his key role also involves technical sales support, client interaction and project management within the healthcare team. lastly, he showcases extensive affinity towards learning new skills and remain fascinated in implementing them.
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
